CpG-C DNA (ODN 2395), Human/ Mouse
ODN 2395 is a prototype of the class of CpG-C oligodeoxynucleotides (ODN) and is particularly effective at activating B- and NK cells and inducing IFN-alpha production in vitro of human peripheral blood mononuclear cells (PBMC). The vertebrate immune system has evolved innate immune defense pattern recognition receptors (PRRs) that detect unmethylated cytosine-phosphate-guanine (CpG) motifs within bacterial DNA. Cellular activation by CpG motifs occurs via the Toll signal pathway. The Toll-like receptor-9 (TLR9, CD289) appears to be a major component of the CpG-DNA receptor, acting by direct binding to CpG-DNA, which triggers the induction of cell signaling pathways including the mitogen activated protein kinase (MAPKs) and NFκB, leading to stimulation of various cells of the immune system. The human TLR9 is expressed in B cells and plasmacytoid dendritic cells (PDC). Mice also express TLR9 in the myeloid compartment. Optimal sequences for activating TLR9 vary among species. Synthetic ODN contain CpG-DNA motifs mimicking the immunostimulatory effects of bacterial DNA and can, therefore, be used as immunoprotective agents, vaccine adjuvants and anti-allergic agents. CpG ODN also affects immune tolerance and autoimmunity. Different classes of CpG ODN are characterized each with distinct effects on the immune response: CpG-A (‘D’-type), CpG-B (‘K’-type), and CpG-C. CpG-C ODN combines the immune effects of CpG-A and -B ODN since they induce strong B-cell activation comparable to CpG-B together with IFN-alpha secretion as CpG-A ODN. Furthermore NK cells isolated from peripheral blood and cultured with CpG-C ODN, in the presence of either IL-12 or IL-8, express higher levels of CD69 as compared to those stimulated with ether CpG-A or CpG-B ODN. Moreover, NK cells cultured with CpG-C ODN displayed higher cytolytic activity against tumor cell lines. In contrast to CpG-A, CpG-C ODN has a complete phosphorothioate (PS) backbone without poly-G motifs, but contains like CpG-A palindromic sequences combined with stimulatory CpG motifs. In vivo studies demonstrate that CpG-C are very potent Th1 adjuvants. Since CpG-C ODN combine the immune effects of both CpG-A and CpG-B, CpG-C might have broader immune therapeutic effects in different tumor types and infectious diseases in which a combination of A- and B-class ODN would be desirable. The prototype sequence of a CpG-C is the 22-mer ODN 2395 that is able to modulate the immune response in both human and mice. It has the following sequence: 5′-tcgtcgttttcggcgcgcgccg-3′. Regular letters represent PS linkage and bold letters represent CpG dinucleotides.
You may also like…
Calculate your ELISA data easily
With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.
Latest Hycult Biotech news
- New Human Complement Pathway AssaysWe are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to address the issue of false negative results, enabling more accurate and reliable analysis of complement… Read more: New Human Complement Pathway Assays
- Navigating the pitfalls in complement analysisOur colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not only the correct technique is used but also that pre-analytical sample handling is performed in… Read more: Navigating the pitfalls in complement analysis
- NEW Human C3d ELISAWe are happy to introduce our new ELISA (cat.# HK3017) designed to detect human C3d. What sets this assay apart is its utilization of a distinctive neo-epitope capture antibody that selectively targets a specific C3d region of the alpha chain, which is not available in other C3 variants. This way it specifically distinguishes C3d from native C3… Read more: NEW Human C3d ELISA